NewGenIvf Group (NIVF) to Post Earnings on Thursday

NewGenIvf Group (NASDAQ:NIVF) is projected to post its resultson Thursday, July 30th. Analysts expect NewGenIvf Group to announce earnings of $556.20 per share and revenue of $2.8720 million for the quarter.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings results on Tuesday, March 31st. The company reported ($861.72) EPS for the quarter. The company had revenue of $1.42 million during the quarter. On average, analysts expect NewGenIvf Group to post $14 EPS for the current fiscal year and $28 EPS for the next fiscal year.

NewGenIvf Group Stock Performance

NewGenIvf Group stock opened at $1.27 on Thursday. The stock has a 50-day simple moving average of $1.98 and a 200 day simple moving average of $7.27. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 52 week low of $1.19 and a 52 week high of $568.53.

Analyst Upgrades and Downgrades

NIVF has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Insider Activity

In other news, major shareholder Financial Lp Hrt sold 28,439 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $2.40, for a total transaction of $68,253.60. Following the completion of the sale, the insider owned 18,187 shares in the company, valued at approximately $43,648.80. This trade represents a 60.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.